Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Venetoclax Combined with Homoharringtonine,Cytarabine and Aclacinomycin (HAAV) As Induction Therapy in Newly Diagnosed Young Adult Acute Myeloid Leukemia

Zepin Zhou, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Zeyan Shi, Yunya Luo, Yaxian Tan, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Heng Li, Weihua Zhao, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu

Blood (2023) 142 (Supplement 1): 1517.

https://doi.org/10.1182/blood-2023-179275

Published: 2023

Journal Articles

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Runxia Gu, Wenbin Liu, Yihan Mei, Le Li, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Benfa Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2023-188950

Published: 2023

Journal Articles

Prognostic Value of MRD By Flow Cytometry in Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen: A Post-Hoc Analysis from a Prospective Study of China

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 6073.

https://doi.org/10.1182/blood-2023-174856

Published: 2023

Journal Articles

Three-Day Decitabine Combined with Venetoclax in Patients with Newly Diagnosed or Relapsed/Refractory AML

Xiaohui Suo, Guanchen Bai, Xingli Zhao, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Xinxiao Lu, Linyu Yuan, Yingchang Mi, Kaiqi Liu

Blood (2023) 142 (Supplement 1): 5942.

https://doi.org/10.1182/blood-2023-181804

Published: 2023

Journal Articles

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Anli Lai, Hui Wei, Ying Wang, Dong Lin, Chunlin Zhou, Bingcheng Liu, Runxia Gu, Yan Li, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Junping Zhang, Yingchang Mi, Shaowei Qiu, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5988.

https://doi.org/10.1182/blood-2023-179966

Published: 2023

Journal Articles

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Blood (2023) 142 (Supplement 1): 827.

https://doi.org/10.1182/blood-2023-184421

Published: 2023

Journal Articles

Optimized Rabbit Antithymocyte Globulin Protocol Plus Sequential Cyclosporine and Levamisole Regimen for Newly Diagnosed Severe Aplastic Anemia: A Single-Arm, Single-Centre, Prospective, Phase 2 Trial

Meili Ge, Jiali Huo, Xiang Ren, Jinbo Huang, Min Wang, Neng Nie, Jing Zhang, Peng Jin, Yingchang Mi, Yingqi Shao, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 2725.

https://doi.org/10.1182/blood-2023-179386

Published: 2023

Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Blood (2023) 142 (Supplement 1): 969.

https://doi.org/10.1182/blood-2023-179205

Published: 2023

Journal Articles

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qi Wang, Qiuling Li, Bo Hu, Kaiqi Liu, Yingchang Mi

Blood (2023) 142 (Supplement 1): 2895.

https://doi.org/10.1182/blood-2023-179087

Published: 2023

Journal Articles

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Kaiqi Liu, Xiaohui Suo, Guanchen Bai, Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qiuling Li, Bo Hu, Yingchang Mi

Blood (2023) 142 (Supplement 1): 4272.

https://doi.org/10.1182/blood-2023-179009

Published: 2023

Journal Articles

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Blood (2023) 142 (Supplement 1): 2949.

https://doi.org/10.1182/blood-2023-185483

Published: 2023

Journal Articles

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

Shichong Wang, Jiali Huo, Yilin Liu, Lingyun Chen, Xiang Ren, Xingxin Li, Min Wang, Peng Jin, Jinbo Huang, Neng Nie, Jing Zhang, Yingqi Shao, Meili Ge, Yingchang Mi, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 2717.

https://doi.org/10.1182/blood-2023-178156

Published: 2023

Journal Articles

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem/Stromal Cell Death Via RIPK1-Independent Necroptosis

Xiang Ren, Meili Ge, Jiali Huo, Jinbo Huang, Min Wang, Yingqi Shao, Yingchang Mi, Yizhou Zheng

Blood (2023) 142 (Supplement 1): 5624.

https://doi.org/10.1182/blood-2023-186067

Published: 2023

Journal Articles

Myeloid Dendritic Cells Were Expanded and Functionally Stronger in Aplastic Anemia

Lingyun Chen, Jiali Huo, Xiang Ren, Shichong Wang, Yilin Liu, Jinbo Huang, Xingxin Li, Min Wang, Peng Jin, Neng Nie, Jing Zhang, Yingqi Shao, Yingchang Mi, Yizhou Zheng, Meili Ge

Blood (2023) 142 (Supplement 1): 5657.

https://doi.org/10.1182/blood-2023-182739

Published: 2023

Journal Articles

Integrative Multi-Omic Analysis for Prognosis Stratification in Acute Myeloid Leukemia

Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Chunlin Zhou, Dong Lin, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi

Blood (2023) 142 (Supplement 1): 5984.

https://doi.org/10.1182/blood-2023-173211

Published: 2023

Journal Articles

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Xin Zhao, Baohang Zhang, Jianping Li, Huihui Fan, Yuan Li, Wenrui Yang, Liping Jing, Li Zhang, Kang Zhou, Youzhen Xiong, Lei Ye, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 2940.

https://doi.org/10.1182/blood-2022-169378

Published: 2022

Journal Articles

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Liping Jing, Yingchang Mi, Huihui Fan, Wenrui Yang, Yuan Li, Jianping Li, Li Zhang, Xin Zhao, Kang Zhou, Lei Ye, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5811–5812.

https://doi.org/10.1182/blood-2022-168380

Published: 2022

Journal Articles

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Xin Zhao, Li Zhang, Bing Han, Tiantian Zhang, Xu Liu, Miao Chen, Changping Li, Huijie Huang, Liping Jing, Kang Zhou, Guangxin Peng, Yuan Li, Jianping Li, Lei Ye, Huihui Fan, Wenrui Yang, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5805–5806.

https://doi.org/10.1182/blood-2022-167951

Published: 2022

Journal Articles

Comparison of Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for Patients with Severe Hepatitis-Associated Aplastic Anemia

Xiaoyu Zhang, Wenrui Yang, Jialin Wei, Rongli Zhang, Guixin Zhang, Xin Chen, Yong Huang, Yingchang Mi, Sizhou Feng, Mingzhe Han, Li Zhang, Yi He, Erlie Jiang

Blood (2022) 140 (Supplement 1): 12941–12942.

https://doi.org/10.1182/blood-2022-165138

Published: 2022

NARROW

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Venetoclax Combined with Homoharringtonine,Cytarabine and Aclacinomycin (HAAV) As Induction Therapy in Newly Diagnosed Young Adult Acute Myeloid Leukemia

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Prognostic Value of MRD By Flow Cytometry in Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen: A Post-Hoc Analysis from a Prospective Study of China

Three-Day Decitabine Combined with Venetoclax in Patients with Newly Diagnosed or Relapsed/Refractory AML

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Optimized Rabbit Antithymocyte Globulin Protocol Plus Sequential Cyclosporine and Levamisole Regimen for Newly Diagnosed Severe Aplastic Anemia: A Single-Arm, Single-Centre, Prospective, Phase 2 Trial

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Impaired Immunosuppressive Effect of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes on T Cells in Aplastic Anemia

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem/Stromal Cell Death Via RIPK1-Independent Necroptosis

Myeloid Dendritic Cells Were Expanded and Functionally Stronger in Aplastic Anemia

Integrative Multi-Omic Analysis for Prognosis Stratification in Acute Myeloid Leukemia

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Comparison of Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for Patients with Severe Hepatitis-Associated Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only